Frontlight ResearchEarly access
CompletedNo phase
Seroprevalence and Risk Factors of H. Pylori Infection in Korea in 2023: Nationwide Multicenter Prospective Study
Key facts
- Who runs it
- Seoul National University Bundang Hospital
- Where
- South Korea1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 19,680 people enrolled
- Started
- 1 Jul 2023
- Ended
- 30 Jun 2024
- Type of study
- Observational, 3 groups
- Record updated
- 13 November 2026
Who can take part
- Age
- 19 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Individuals undergoing routine health screening at 10 healthcare centers in South Korea between July 2023 and December 2024. The study included participants who underwent Helicobacter pylori serologic testing and gastrointestinal endoscopic examinations
Who cannot take part
- History of colectomy
- Inflammatory bowel disease
- Gastric cancer or a history of gastrectomy for gastric cancer
- Individuals without colonoscopy or esophagogastroduodenoscopy records
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Helicobacter pylori Infection in South Korea: Seroprevalence, Risk Factors, and Association with Colorectal Adenoma
The 3 groups in the trial
- The never-exposed group
negative IgG results and no prior eradication therapy
- The eradicated group
seronegative participants with a history of eradication therapy, participants with weakly positive IgG results were also classified into the eradicated group if a negative result was documented on an additional post-treatment confirmatory test, such as a urea breath test or rapid urease test, or if they reported during a structured interview that successful eradication had been confirmed after treatment
- The seropositive group
positive IgG titers who did not meet the criteria for the eradicated group
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Seroprevalence and Risk Factors of Helicobacter Pylori Infection in Korea in 2023 - Nationwide Multicenter Prospective Study -
- Record updated
- 13 November 2026